Placebo on a 0- and 28-day schedule

BIOLOGICAL2 trials

Sponsors

Institute of Medical Biology, Chinese Academy of Medical Sciences

Conditions

COVID-19

Phase 1

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

CompletedNCT04412538

Institute of Medical Biology, Chinese Academy of Medical SciencesCOVID-19

Start: 2020-05-15End: 2021-08-31Updated: 2023-10-11

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years

CompletedNCT04470609

Institute of Medical Biology, Chinese Academy of Medical SciencesCOVID-19

Start: 2020-07-10End: 2021-10-27Updated: 2023-10-11

Related Papers

The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.

2021-04-0937 citations

Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults

Clinical Infectious Diseases2020-11-0672 citations